CALIXAR Best Inventing French-Tech Company 2018

May 16, 2018

Lyon (France), May 16, 2018 – CALIXAR, the French biotech company specialized in the native isolation of complex therapeutic targets and antigens, is proud to announce its nomination by in Forbes as Best Inventor 2018 of the French Auvergne-Rhône Region among French-Tech start-up companies. At the national level CALIXAR reaches the 38th place out of the Top 100.

This ranking takes into account the total number of different patented inventions hold by each company. With a strong portfolio of 7 patent families, and despite a strong competition, CALIXAR has been able to take the first place of its region.

More information here (article in French).

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.